© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Dalbavancin Hydrochloride stands out in the world of antibiotics as a semi-synthetic lipoglycopeptide. Structurally, this compound has drawn interest for its advanced properties, rooted in its complex molecular arrangement. With a chemical formula of C88H100Cl2N10O28 and a molecular weight hovering around 1817 g/mol, the molecule brings potent antibacterial effects that prove pivotal in health care. It’s built on a foundation combining peptide backbones with aromatic rings and long hydrophobic side chains, features that support its unique activity. Rather than simply mimicking older antibiotics, the molecule’s structure enables it to bind effectively to specific bacterial cell wall components, cutting off the process pathogens use to build a protective shell. This chemistry isn’t abstract — it translates directly into its utility in fighting serious infections where simpler drugs no longer work.
Dalbavancin Hydrochloride takes the form of an off-white to pale yellow solid. People working with this compound describe the raw material as fine powder, sometimes appearing as crystalline flakes, depending on production method and storage conditions. In lab settings, the powder proves highly hygroscopic, meaning it absorbs moisture if left exposed, a trait that forces careful packaging and storage. Density figures settle close to 1.68 g/cm³. Dissolving it in water produces a clear solution, and the pH of such solutions lines up with the needs of pharmaceutical compounding. Flakes and powder forms offer safe handling, as the material does not dust out of control or clump unless humidity rises. The substance stays stable at room temperature and resists breakdown when capped and shielded from direct light. Crystal forms show consistent structure under magnification, testifying to purity when produced correctly. Density, form, and stability all matter because these factors determine how easily the compound integrates into injectable suspensions or reconstituted solutions in the clinic.
Expanding on what’s inside each granule or flake, the molecular structure of Dalbavancin Hydrochloride looks like a tapestry of interconnected rings, sugars, and long hydrocarbon tails. This structure makes the molecule heavy and complex, but that complexity gives it the leverage to lock onto its bacterial targets with stubborn persistence. As a raw material, the substance checks several boxes that manufacturers track: it keeps a reliable melting point, does not vaporize under normal lab conditions, and dissolves fully in most buffered saline solutions. One familiar concern in chemistry circles is solubility, since some antibiotics form sticky, insoluble masses unless tweaked — Dalbavancin Hydrochloride sidesteps that by dissolving consistently above 75 mg/mL in water. Property tables from trusted suppliers back this claim, driving confidence among pharmacists who prepare intravenous infusions for patients fighting life-threatening MRSA infections.
Every time a pallet of Dalbavancin Hydrochloride ships across international borders, customs officers assign it an HS Code for tracking and regulatory clarity. That code — 2941.90 for antibiotics of this class — does more than satisfy paperwork. Regulators use it to ensure the compound gets tested and registered for legal pharmaceutical production. Handling guidelines classify Dalbavancin Hydrochloride as a non-volatile solid with low flammability risks, yet its status as a potent antibiotic makes chemical exposure a matter of caution. In the lab, gloves go on before anyone opens a vial, and spills require cleanup with water and detergent rather than dry sweeping, which could kick particles into the air. Material safety data sheets call attention to possible eye or skin irritation but do not link the material to acute environmental harm or high toxicity in humans. Still, people in pharmaceutical manufacturing pay extra attention to minimizing exposure, partly to prevent inadvertent sensitization or development of antibiotic-resistant bacteria where the material is handled recklessly.
Specifications for pharmaceutical-grade Dalbavancin Hydrochloride demand tight control over content and contaminants. Purity levels exceed 98% for active compound, with water content, residual solvents, and trace metals held below regulatory cutoffs. The exact shape of the flakes or consistency of the powder matters in automated production, as uniformity ensures easy weighing, smooth blending, and no surprises at the vial-filling stage. When dissolved, the solution should be essentially colorless to pale yellow, without suspended particles — an indicator that no degradation or microbial contamination has occurred. Pharmacies often receive the antibiotic as a dry material, ready to mix with sterile water or dextrose before injection, a process that calls for reliable solubility and stability. Clinical staff rely on those standards for safe dosing, confident that the molecular structure remains intact through reconstitution and storage in saline bags.
As with most pharmaceuticals, Dalbavancin Hydrochloride must be handled respectfully. It does not cause acute toxicity in most lab settings, but inhaling large amounts of powder, or accidental injection, would trigger harmful effects. The chemical classification as non-carcinogenic and non-mutagenic comes from repeated toxicity studies, and each batch is tested for possible pyrogens or harmful breakdown products before shipping from the supplier. Safety instructions advise against direct skin or lung contact, although basic personal protection, like lab coats and face shields, keeps risks manageable. Environmental guidelines call for prevention of bulk disposal through municipal wastewater: antibiotics like Dalbavancin, in any form, can interfere with environmental bacterial balances if released unchecked. Manufacturers design waste streams to collect wash water and process byproducts for incineration or chemical neutralization, following Good Manufacturing Practice (GMP) frameworks. Using shared lab space without containment protocols, or disposing of materials in regular trash, can create resistant organisms or expose workers to unnecessary chemical hazards, so internal audits and compliance checks happen routinely.
One problem that pops up with compounds like Dalbavancin Hydrochloride shows up far from the lab bench — in hospitals, where resistant infections have outstripped many older antibiotics. Dalbavancin’s physical and molecular properties offer one answer to the threat, but misuse could ruin its effectiveness. Doctors have to track dosing, stick closely to approved guidelines, and resist the pressure to use this antibiotic for unproven cases. On the pharmaceutical supply side, counterfeit batches or substandard raw materials can slip past weak regulation, which means tracking every vial, batch, and shipment from synthesis to pharmacy matters as much as the chemistry itself. Suppliers respond by offering third-party verification, full traceability down to raw material lots, and supply chain audits to weed out fakes. International health bodies follow the trail through customs with the HS Code, sampling random shipments and requiring proof of compliance against pharmacopeia benchmarks. Keeping Dalbavancin Hydrochloride working for patients in need takes daily vigilance, not only in the clinic, but also in every link of the chemical and pharmaceutical chain.
